Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2012
Novel therapeutic agents for the management of patients with multiple myeloma and renal impairmentAsher A Chanan-Khan, Jesús F San Miguel, Sundar Jagannath, et al.
Case Reports in Hematology|March 10, 2020
Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature ReviewRicardo D Parrondo, Vivek Roy, Taimur Sher, et al.
Oncology|June 7, 2014
Outcome disparities among ethnic subgroups of Waldenström's macroglobulinemia: a population-based studySikander Ailawadhi, Adel Kardosh, Dongyun Yang, et al.
British Journal of Haematology|January 12, 2011
Inhibition of heat shock protein 90 (HSP90) as a therapeutic strategy for the treatment of myeloma and other cancersPaul G Richardson, Constantine S Mitsiades, Jacob P Laubach, et al.
Blood|July 10, 2015
Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myelomaA Keith Stewart, Susanna Jacobus, Rafael Fonseca, et al.
British Journal of Haematology|July 13, 2010
Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation studyPaul G Richardson, Asher A Chanan-Khan, Melissa Alsina, et al.
International Journal of Hematology|July 4, 2012
Lenalidomide in combination with dexamethasone improves survival and time-to-progression in patients ≥65 years old with relapsed or refractory multiple myelomaAsher A Chanan-Khan, Sagar Lonial, Donna Weber, et al.
Plos One|April 9, 2015
Immunophenotyping of Waldenströms macroglobulinemia cell lines reveals distinct patterns of surface antigen expression: potential biological and therapeutic implicationsAneel Paulus, Kasyapa S Chitta, Paul K Wallace, et al.
American Journal of Clinical Pathology|March 21, 2012
Monoallelic and biallelic deletions of 13q14.3 in chronic lymphocytic leukemia: FISH vs miRNA RT-qPCR detectionMatthew T Smonskey, AnneMarie W Block, George Deeb, et al.
Cancer Medicine|December 29, 2017
Second primary acute lymphoblastic leukemia in adults: a SEER analysis of incidence and outcomesAbhisek Swaika, Ryan D Frank, Dongyun Yang, et al.
Pageof 9